Oral chemotherapy prescription safety practices in Europe
Impact of findings on practice
Two recent surveys on oral chemotherapy from Spain and France provide novel data in a European setting on this field.
Depending on the country, oral chemotherapy can be dispensed by community pharmacists or by hospital pharmacists, with notable differences in their involvement in the safety practices.
It is valuable to have a hospital pharmacist with experienced in oncology to be directly involved in the education also when an oral antineoplastic agent is dispensed to minimize potential errors, improve patient outcomes and compliance.
Recently, Bourmaud et al.  published a very well conducted study on oral chemotherapy prescription survey in France. This study, together with a recent publication of our group on oral chemotherapy safety and adherence practices in Spain, provides novel data in a European setting on this field . We believe it could be instrumental to briefly compare both studies to understand similarities as well as...
KeywordsCommunity Pharmacist Safety Practice Hospital Pharmacist Oral Chemotherapy Double Check
The authors would like to thank Dr. Aurelie Bourmaud for providing further information about the role of community pharmacists and the dispensing of oral chemotherapy in France. The study of reference is an initiative born in a consolidated group of hospital pharmacists who work to improve quality of oncohematological care, the Spanish Group for the Development of Oncological Pharmacy (GEDEFO, Grupo Español para el Desarrollo de la Farmacia Oncológica).
Conflicts of interest
- 1.Bourmaud A, Pacaut C, Melis A, Tinquaut F, Magne N, Merrouche Y, et al. Is oral chemotherapy prescription safe for patients? A cross-sectional survey. Ann Oncol. 2014;25:500–4.Google Scholar